Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
American Journal of Hematology
|
June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience
Chezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.
BMJ Open
|
January 26, 2022
Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma-a phase 3 randomised trial
Peey Sei Kok, Patrick M Forde, Brett Hughes, et al.
Haematologica
|
November 24, 2018
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900
Hugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Cancer
|
May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis
James M Foran, Zhuoxin Sun, Catherine Lai, et al.
Leukemia Research
|
November 4, 2022
Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling
Chezi Ganzel, Zhuoxin Sun, Timour Baslan, et al.
Cancer Genetics
|
March 12, 2014
Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants
Cathy C Laurie, Cecelia A Laurie, Stephanie A Smoley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2008
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial
Diana Crivellari, Zhuoxin Sun, Alan S Coates, et al.
Blood
|
January 13, 2016
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups
Marlise R Luskin, Ju-Whei Lee, Hugo F Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2021
Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin
Alan F List, Zhuoxin Sun, Amit Verma, et al.
JCI Insight
|
July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
Marlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
American Journal of Hematology
|
June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience
Chezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.
BMJ Open
|
January 26, 2022
Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma-a phase 3 randomised trial
Peey Sei Kok, Patrick M Forde, Brett Hughes, et al.
Haematologica
|
November 24, 2018
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900
Hugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Cancer
|
May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis
James M Foran, Zhuoxin Sun, Catherine Lai, et al.
Leukemia Research
|
November 4, 2022
Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling
Chezi Ganzel, Zhuoxin Sun, Timour Baslan, et al.
Cancer Genetics
|
March 12, 2014
Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants
Cathy C Laurie, Cecelia A Laurie, Stephanie A Smoley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2008
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial
Diana Crivellari, Zhuoxin Sun, Alan S Coates, et al.
Blood
|
January 13, 2016
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups
Marlise R Luskin, Ju-Whei Lee, Hugo F Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2021
Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin
Alan F List, Zhuoxin Sun, Amit Verma, et al.
JCI Insight
|
July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
Marlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
Page
of 8